The Thomson/First Call price target on the stock is $49.30. The stock opened Friday at $ ... Medivation opened Friday at $68.30. NPS Pharmaceuticals Inc. (NASDAQ: NPSP) could have a solid year. CEO Francois Nader told Wall Street analysts to expect an ...
Yang downgraded the rating on NPS Pharmaceuticals (NASDAQ ... Gattex U.S. launch in 2013 and anticipation of bigger Natpara opportunity resulted in strong stock performance. Now trading at ~17.2x EV/'14 revenue (vs. ~16.1x for BMRN and ~17.5x for ALXN ...
New York, NY - (ACCESSWIRE) - 11/06/2013 - Growing Stock Report initiates its NASDAQ Active Stock Watch List adding Myriad Genetics Inc. (NASDAQ:MYGN - News), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP - News), Durata Therapeutics, Inc. (NASDAQ:DRTX - News ...
(Reuters) - Dublin-based Shire Plc (SHP.L), whose proposed sale to AbbVie Inc (ABBV.N) fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals ... up 1.3 percent on the London Stock Exchange. The timing of a possible ...
Reuters · 3y
Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals ... any shares held by NPS Pharma as treasury stock (other than any shares held in an NPS Pharma benefit ...
4-Traders · 3y
BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ ... previously licensed to Takeda GmbH and the assets related to the two products for common stock valued at $50 million. “The launch of Gattex is off to an excellent start and while ...
Shire plc (NASDAQ: SHPG) the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals ... offer (excluding any shares held by NPS Pharma as treasury stock (other than any shares held in an NPS Pharma benefit ...
This weekend, the big-dog specialty biopharmaceutical company Shire (London Stock Exchange: SHP-GB) announced that it will acquire NPS Pharmaceuticals (NPSP), at a 51 percent premium to where it was trading before. NPS is a developer of orphan drugs that ...
CHICAGO, April 9, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DDD, ATVI, AIG, YPF, and NPSP. To see what our analysts ... detailed strategies for each stock we cover, including position protection tactics …